Potential of the Cardiovascular Drug Levosimendan in the Management of Amyotrophic Lateral Sclerosis: An Overview of a Working Hypothesis

Ammar Al-Chalabi, Leo M. A. Heunks, Zoltan Papp, Piero Pollesello

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)389-399
JournalJournal of Cardiovascular Pharmacology
Issue number5
Publication statusPublished - Nov 2019

Cite this